Abstract
To characterize the physicochemical and biological stability of nanodevices suitable for biomedical applications, polylactic acid (PLA) nanoparticles (NPs) of 112 ± 6 nm and polyhydroxy butyrate (PHB) of 15 ± 5 nm size were prepared by standardizing the suitable method for each. Morphology of NPs was studied by scanning and transmission electron microscopy and temperature stability by thermogravimetric analysis. Their stability in biological fluids (simulated gastrointestinal and saliva) and tolerance against 0.5 mM NaCl were analyzed. PHB NPs remained stable in all fluids, while after 24 h treatment, the PLA NPs showed the beginning of disintegration with intestinal fluid mimic. In addition to the preparation of polyethylene glycol (PEG) surface-coated NPs, PLA–PEG–PLA triblock copolymer (MW ∼ 7,366 Da) was also chemically synthesized and characterized. Cytotoxicity of all forms of nanoparticles was tested by MTT assay and by annexin pi staining.
Similar content being viewed by others
References
Khor, E., & Lim, L. Y. (2003). Biomaterials, 24, 2339–2349.
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005). The Journal of the federation of American Societies for Experimental Biology, 19, 311–330.
Nair, N. R., Nampoothiri, K. M., & Pandey, A. (2012). Biotechnology Letters, 34(11), 2031–2035.
Chen, C., Yu, C. H., Cheng, Y. C., Yu, P. H. F., & Cheung, M. K. (2006). Biomaterials, 27, 4804–4814.
Tobio, M., Sanchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., & Alonso, M. J. (2000). Colloids and Surfaces B: Biointerfaces, 18, 315–323.
Ogawa, Y., Yamamoto, M., Okada, T., Yashiki, T., & Shimamoto, T. (1988). Chemical and Pharmaceutical Bulletin, 36, 1095–1103.
Govender, T., Snjezana, S., Martin, C., Garnett, I. L., & Davis, S. S. (1999). Journal of Controlled Release, 57, 171–185.
Alonso, M. J., Gupta, R. K., Min, C., Siber, G. R., & Langer, R. (1994). Vaccine, 12, 299–306.
Chenana, M., Gil, P. R., Miguel, A., Correa, D., Luis, M., Liz, M., & Wolfgang, J. P. (2013). Angewandte Chemie International Edition, 52, 4179–4183.
Scholes, P. D., Coombes, A. G. A., Illum, L., Davis, S. S., Vert, M., & Davies, M. C. (1993). Journal of Controlled Release, 25, 145–153.
Asadi, H., Rostamizadeh, K., Salari, D., & Hamidi, M. (2011). Journal of Microencapsulation, 28(5), 406–416.
Lazzari, S., Davide, M., Fabio, C., Mario, S., Massimo, M., & Luisa, D. (2012). Journal of Nanoparticle Research, 14, 92.
Barker, S. B., & Summerson, W. H. (1941). Journal of Biology and Chemistry, 138, 535–554.
Leach, K. J., & Mathiowitz, E. (1998). Biomaterials, 19, 1973–1980.
Essa, S., Rabanel, J. M., & Hildgen, P. (2010). European Journal of Pharmaceutics and Biopharmaceutics, 75, 96–106.
Fresta, M., Fontana, G., Bucolo, C., Cavallallaro, G., Giammona, G., & Puglisi, G. (2001). Journal of Pharmaceutical Sciences, 90, 288–297.
Tice, T. R., & Gilley, R. M. (1985). Journal Control Release, 2, 343–352.
Fessi, H., Puisieux, F., Devissaguet, J. P., Amoury, N., & Benita, S. (1989). International Journal of Pharmaceutics, 113, r1–r4.
Peltonen, L., Koistinen, P., Karjalainen, M., Hakkinen, A., & Hirvonen, J. (2002). American Association of Pharmaceutical Scientists, 3, E32.
Wehlre, P., Magenheim, B., & Benita, S. (1995). European Journal of Pharmaceutics and Biopharmaceutics, 41, 19–26.
Valo, H., Peltonen, L., Vehvilainen, S., Karjalainen, M., & Kostiainen R, et al. (2009). Small, 1791–1798.
Shakweh, M., Besnard, M., Nicolas, V., & Fattal, E. (2005). European Journal of Pharmaceutics and Biopharmaceutics, 61, 1–13.
Sendo, T., Teshima, D., Makino, K., Mishima, K., Itoh, Y., et al. (2002). Journal of Clinical Pharmacy and Therapeutics, 27, 79–84.
Hunter, R. J. (1981). Zeta potential in colloid science principles and applications (p. 386). New York: Academic.
Benita, S., & Levy, M. Y. (1993). Journal of Pharmaceutical Sciences, 82, 1069–1079.
Xiong, Y. C., Yao, Y. C., Zhan, X. Y., & Chen, G. Q. (2010). Journal Biomaterials Sciences Polymer, 21, 127–140.
Xiao, R. Z., Zeng, Z. W., Zhou, G. L., Wang, J. J., Li, F. Z., & Wang, A. M. (2010). International Journal of Nanomedicine, 5, 1057–1065.
Mohs, A. M., Duan, H. W., Kairdolf, B. A., Smith, A. M., & Nie, S. M. (2009). Nano Research, 2(6), 500–508.
Kuentz, M. (2008). American Association of Pharmaceutical Scientists, 10, 473–479.
Win, K. Y., & Feng, S. S. (2005). Biomaterials, 26(15), 2713–2722.
Ropert, D. C., Bazile, J., Brendenbach, M., Marlard, M., Veillard, G., & Spenlehauer. (1993). Colloids and Surfaces B: Biointerfaces, 1, 233–239.
Landry, F. B., Bazile, D. V., Spenlehauer, G., Veillard, M., & Kreuter, J. (1996). S.T.P. Pharmacology Sciences, 6(3), 195–202.
Tobrio, M., Gref, R., Sánchez, L. R., & Alonso, M. J. (1998). Pharmaceutical Research, 15(2), 270–275.
Jain, A. K., Goyal, A. K., Mishra, N., Vaidya, B., Mangala, S., & Vyas, S. P. (2010). International Journal of Pharmaceutics, 387, 253–262.
Acknowledgments
We thank the financial support from CSIR, New Delhi under the XIIth five year plan network project, BIODISCOVERY (BSC 120).
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Supplementary Table 1
(DOC 32 kb)
Supplementary Table 2
(DOC 30 kb)
Supplementary Figure 1
(DOC 799 kb)
Rights and permissions
About this article
Cite this article
Moorkoth, D., Nampoothiri, K.M. Synthesis, Colloidal Properties and Cytotoxicity of Biopolymer Nanoparticles. Appl Biochem Biotechnol 174, 2181–2194 (2014). https://doi.org/10.1007/s12010-014-1172-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-014-1172-z